SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (2)2/6/1999 7:23:00 PM
From: Mike McFarland  Read Replies (1) of 319
 
Some more companies,
Vical of course, forgot that one for a moment.

Here are a couple of blurbs off the last Transgene
PR too--

-- Entered into a research collaboration and licensing agreement
with Schering-Plough to develop gene therapy products based on TRANSGENE's adenoviral technology.
-- Signed an agreement with HGSI to accelerate the development
of novel gene therapy drugs. Received equity investment from
HGSI for a 10% stake in TRANSGENE.

note
techstocks.com
techstocks.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News